Multicentric Phase II Randomized Trial Comparing Chemoradiation (CHRT) with 5-Fluorouracil, Cisplatin (CDDP) and 50 GY versus Chemotherapy Alone (CH) with Gemcitabine (G) Plus Oxaliplatin (O) for Locally advanced Biliary Tract Cancer (FFCD9902)

Annals of Oncology ◽

10.1016/s0923-7534(20)33310-x ◽

2012 ◽

Vol 23 ◽

pp. ix242

Author(s):

J.M. Phelip ◽

V. Vendrely ◽

J. Jouve ◽

F. Subtil ◽

M. Gasmi ◽

...

Keyword(s):

Randomized Trial ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Locally Advanced ◽

Tract Cancer

Download Full-text

Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e15150 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e15150-e15150

Author(s):

Eun-Kee Song ◽

Hye-Suk Han ◽

Ki Hyeong Lee ◽

Kyu Taek Lee ◽

Sang Byung Bae ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Tract Cancer ◽

Multicenter Phase

Download Full-text

Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised study

European Journal of Cancer ◽

10.1016/j.ejca.2014.08.013 ◽

2014 ◽

Vol 50 (17) ◽

pp. 2975-2982 ◽

Cited By ~ 18

Author(s):

Jean-Marc Phelip ◽

Véronique Vendrely ◽

Florian Rostain ◽

Fabien Subtil ◽

Jean-Louis Jouve ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Locally Advanced ◽

Randomised Study ◽

Tract Cancer ◽

Cancérologie Digestive

Download Full-text

A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy

European Journal of Cancer ◽

10.1016/j.ejca.2021.06.019 ◽

2021 ◽

Vol 154 ◽

pp. 288-295

Author(s):

In Sil Choi ◽

Ki Hwan Kim ◽

Ju Hyun Lee ◽

Koung Jin Suh ◽

Ji-Won Kim ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

First Line ◽

Tract Cancer

Download Full-text

A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000347 ◽

2018 ◽

Vol 41 (7) ◽

pp. 649-655 ◽

Cited By ~ 14

Author(s):

Renuka V. Iyer ◽

Venkata K. Pokuri ◽

Adrienne Groman ◽

Wen W. Ma ◽

Usha Malhotra ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Tract Cancer ◽

Multicenter Phase

Download Full-text

3529 POSTER A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71032-7 ◽

2007 ◽

Vol 5 (4) ◽

pp. 268

Author(s):

J.S. Chen ◽

Y. Chao ◽

T.S. Yang ◽

L.T. Chen ◽

K.D. Lee ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

High Dose ◽

Line Treatment ◽

First Line ◽

Tract Cancer ◽

First Line Treatment

Download Full-text

Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study

Digestive and Liver Disease ◽

10.1016/j.dld.2018.11.018 ◽

2019 ◽

Vol 51 (2) ◽

pp. 318-320 ◽

Cited By ~ 15

Author(s):

Jean-Marc Phelip ◽

Julien Edeline ◽

Jean-Frédéric Blanc ◽

Emilie Barbier ◽

Pierre Michel ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Study Protocol ◽

Biliary Tract Cancer ◽

Locally Advanced ◽

First Line ◽

Tract Cancer ◽

Randomized Controlled ◽

Multicenter Phase ◽

Line Chemotherapy

Download Full-text

48P (BREGO) Regorafenib combined with modified m-GEMOX in patients with advanced biliary tract cancer (BTC): A phase II randomized trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.327 ◽

2021 ◽

Vol 32 ◽

pp. S376-S377

Author(s):

E. Assenat ◽

J.F. Blanc ◽

M. Bouattour ◽

L. Gauthier ◽

Y. Touchefeu ◽

...

Keyword(s):

Randomized Trial ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Tract Cancer

Download Full-text

Faculty Opinions recommendation of Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995584.793475609 ◽

2013 ◽

Author(s):

Piero Portincasa ◽

Leonilde Bonfrate

Keyword(s):

Folinic Acid ◽

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Phase Ii Study ◽

Hepatic Arterial Infusion ◽

Arterial Infusion ◽

Tract Cancer

Download Full-text

Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer

Annals of Oncology ◽

10.1093/annonc/mds008 ◽

2012 ◽

Vol 23 (9) ◽

pp. 2341-2346 ◽

Cited By ~ 60

Author(s):

L.H. Jensen ◽

J. Lindebjerg ◽

J. Ploen ◽

T.F. Hansen ◽

A. Jakobsen

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Wild Type ◽

Tract Cancer

Download Full-text

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

European Journal of Cancer ◽

10.1016/j.ejca.2014.09.013 ◽

2014 ◽

Vol 50 (18) ◽

pp. 3125-3135 ◽

Cited By ~ 68

Author(s):

M. Moehler ◽

A. Maderer ◽

C. Schimanski ◽

S. Kanzler ◽

U. Denzer ◽

...

Keyword(s):

Biliary Tract ◽

Phase Ii ◽

Biliary Tract Cancer ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Tract Cancer

Download Full-text